教育背景
2008.09-2012.12,上海交通大学,生命科学技术学院,生物医学工程,博士,导师:徐宇虹教授
2004.09-2008.06,上海交通大学,生命科学技术学院,生物工程,学士
工作经历
2017.05-至今,江苏大学,药学院,药剂学系,副教授
2013.03-2017.04, 江苏大学,药学院,药剂学系,讲师
项目课题经历
主要科研项目:
1、江苏省自然科学基金面上项目(BK20181445),201807-202106,主持。
2、国家自然科学基金青年科学基金项目(81402880),201501-201712,主持。
3、江苏省自然科学基金青年项目(BK20130541),201307-201607,主持。
4、江苏大学高级人才科研启动基金(14JDG163),201407-202006,主持。
5、国家自然科学基金青年科学基金项目(81102395),201201-201412,参加。
论文、成果、著作等
代表性论文:
1. Chunlai Feng, Haisheng Zhang, Jiaming Chen, Siqi Wang, Yuanrong Xin, Yang Qu, Qi Zhang, Wei Ji, Fumiyoshi Yamashita, and Mengjie Rui*. Ratiometric Co-Encapsulation and Co-Delivery of Doxorubicin and Paclitaxel by Tumor-Targeted Lipodisks for Combination Therapy of Breast Cancer. International journal of pharmaceutics, 560 (2019): 191-204.
2. Chunlai Feng, Xianqin Yuan, Kexin Chu, Haisheng Zhang, Wei Ji, and Mengjie Rui*. Preparation and Optimization of Poly (Lactic Acid) Nanoparticles Loaded with Fisetin to Improve Anti-Cancer Therapy. International journal of biological macromolecules, 125 (2019): 700-10.
3. Hailing Tang, Mengjie Rui, Chuang Yu, Tao Chu, Chao Li, Zhenzhen Zhan, Hao Cao, Hangwen Li, Zhongmin Liu, and Haifa Shen. Nanotechnology in Generation and Biomedical Application of Induced Pluripotent Stem Cells. Nano Life, 8, no. 04 (2018): 1841002.
4. Qi Zhang, Jian Zhang, Song Xue, Mengjie Rui, Bin Gao, Ang Li, Jiashuai Bai, Zhichao Yin, and Ebubedike Mitchelle Anochie. Enhanced Enantioselectivity of Native Α‐Cyclodextrins by the Synergy of Chiral Ionic Liquids in Capillary Electrophoresis. Journal of separation science, 41, no. 24 (2018): 4525-32.
5. Chunlai Feng#, Mengjie Rui#, Haijun Shen, Yuanrong Xin, Jie Zhang, Jun Li, Lixiang Yue, Wenlong Lai, Ximing Xu*.Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer, International Journal of Pharmaceutics, 2017, 528 (1-2):322-333.
6. Mengjie Rui#, Yuanrong Xin , Ran Li, Yanru Ge, Chunlai Feng*, and Ximing Xu*. Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin, Molecular Pharmaceutics, 2017, 14 (1): 107-123.
7. Mengjie Rui#, Yang Qu, Tong Gao, Yanru Ge, Chunlai Feng*, and Ximing Xu*. Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells, International Journal of Nanomedicine, 2017, 12: 217-237.
8. Mengjie Rui#, Hailing Tang, Yan Li, Xiaohui Wei, and Yuhong Xu*. Recombinant High Density Lipoprotein Nanoparticles for Target-Specific Delivery of siRNA. Pharmaceutical research, 2013, 30 (5): 1203-14.
9. Mengjie Rui#, Wei Guo, Qian Ding, Xiaohui Wei, Jianrong Xu, and Yuhong Xu*. Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver. International journal of nanomedicine, 2012, 7: 3751-3768.
10. Hailing Tang, Xiaojing Chen, Mengjie Rui, Wenqiang Sun, Jian Chen, Jinliang Peng, and Yuhong Xu*. Effects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumor. Molecular Pharmaceutics, 2014, 11 (10): 3242–3250.
11. Yan Li, Mengjie Rui, Hailing Tang, and Yuhong Xu*. The distribution and cell uptake of ApoA1 modified lipid carriers of siRNA in mouse liver in vivo. Asian Journal of Pharmaceutical Sciences, 2013, 8: 228-233.
12. Junhua Mai, Shuxian Song, Mengjie Rui, Dan Liu, Qian Ding, Jinliang Peng, Yuhong Xu*. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells. Journal of Controlled Release, 2009, 139 (3): 174–181. 2009.
13. Xiaomeng Zhang*, Huanjun Yang*, Ke Gu, Jian Chen, Mengjie Rui, and Guo-Liang Jiang. In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer. International journal of nanomedicine, 2011, 6: 437-444.
专利、著作版权等
声明:本站专家信息来源于各高校官网。